ArticleVaccines2022

A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222.

Rapisa Nantanee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.